Participated · Seed · Aug 2026

Exclaim Robotics develops mobile robots that autonomously navigate data halls, access rack fronts and perform hands-on maintenance tasks inside live server racks. Its initial scope focuses on narrow, high-frequency interventions such as cleaning and replacing fibre-optic connectors and SFPs, handling copper cabling, and swapping failed drives. The company emphasizes operating safely inside live 800-volt racks and aims to reduce labour-intensive manual maintenance while improving operational efficiency for data centre operators. Founder Helen Oleynikova, who has prior robotics experience at Google, Microsoft, Nvidia, Willow Garage and ETH Zürich, leads the team alongside founding engineer Patrick Pfreundschuh, with two more founding engineers planned to join in 2027. Exclaim has positioned itself alongside startups such as Boost Robotics, Watney Robotics and Gecko Robotics in the data-centre robotics market and has stated goals of accelerating product development using its recent funding.

Participated · Seed · Feb 2026

Founded in 2023 as an ETH Zurich and Empa spin-off, Zurich-based Chiral is building equipment systems and process technology that make nanomaterials manufacturable for cutting-edge semiconductor and quantum applications. Its core offering automates nanomaterial deposition and integration, providing precise process control that accelerates customers’ R&D and production timelines. The company has already delivered its first commercial equipment platform and reports that industrial and research customers are using it to speed development cycles. Recent work has focused on advancing automation and in-line process monitoring to ensure scalability and reliability. With fresh funding, Chiral plans to broaden its operational footprint, deepen product development, and expand customer support. While revenue and user numbers were not disclosed, the company’s progress from prototype to commercial system within two years underscores rapid execution. CEO Seoho Jung leads a multidisciplinary team combining materials science, engineering, and manufacturing expertise.

Participated · Seed · Dec 2025

Navier develops Agent-Driven Engineering (ADE) software in which AI agents automate the repetitive, cross-disciplinary tasks that slow traditional CAD and simulation-based workflows. The cloud platform combines AI agents, compute infrastructure, and tool integrations to let small hardware teams achieve in days what once required large departments weeks, effectively tripling output and compressing development cycles from months to weeks. Drawing on autonomous-vehicle-grade computer vision and spatial reasoning, the agents interpret 3D geometry, set up simulations in minutes, and run continuous validation with automated reporting. This consolidation eliminates the need for multiple software vendors and reduces costly design-engineering misalignments. Navier targets aerospace and automotive customers, positioning ADE as the next major productivity leap after CAD and simulation. The company was founded by CEO Cameron Flannery and operates out of San Francisco. Proceeds from its recent seed financing will fund further platform development and sector expansion.

Participated · Seed · Jun 2025

Lendurai develops on-board autonomous navigation solutions for UAVs that enable operation in GPS- and radio-denied environments. Its proprietary autonomy stack runs advanced AI fully on-board and the platform supports interchangeable payloads to increase flexibility and survivability. The company targets defence customers initially—positioning its products for NATO and allied forces—and says commercial use cases will follow. Lendurai’s systems have been tested and evaluated in challenging operational environments, including active conflict zones, and require less than two days of operator training versus around eight weeks for most FPV systems. Products are manufactured in Estonia using European components, are NDAA-compliant, and described as ready for procurement and deployment. The company recently closed a seed round to fund go-to-market strategies and global expansion.

Led · Seed · May 2025

kyron.bio has developed a platform that fully controls N-glycosylation to precisely define glycans on therapeutics, addressing immune recognition and variable efficacy in antibody drugs. The platform combines novel engineered CHO cell lines and a proprietary glycan-engineering toolbox to enable comprehensive control of glycosylation during production. It achieves over 97% consistency in glycan structures and is offered as a scalable, plug-and-play solution compatible with standard biopharma manufacturing techniques. This level of control is intended to prevent unwanted immune attack, improve therapeutic stability and targeting, and unlock new antibody engineering opportunities. The company announced a €5.5M funding round to accelerate development of its glycan-engineering platform, expand the team and fund preclinical studies. The funding also coincides with the launch of the company’s EIC Transition project backed by the European Innovation Council.